Literature DB >> 27981791

The role of imaging in the surveillance and diagnosis of hepatocellular cancer.

Gurjeet Dulku1, Ravinder Dhillon2, Mark Goodwin3, Wendy Cheng4, Nick Kontorinis4, Richard Mendelson1.   

Abstract

A decision support tool has been developed as part of a suite of on-line evidence-based and consensus-based guidelines Diagnostic imaging Pathways (DIP): www.imagingpathways.health.wa.gov.au) in the form of an algorithmic flow chart with supporting evidence and consensus to inform referrers to diagnostic imaging and radiologists as to the optimum strategy for surveillance and diagnosis of primary hepatocellular cancer (HCC) in those patients with risk factors of this disease. A literature review, including reference to several international consensus-based expert guidelines, has been employed to develop this tool.
© 2016 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  zzm321990MRIzzm321990; PET/CT; diagnosis and surveillance; hepatocellular carcinoma; ultrasound

Mesh:

Year:  2016        PMID: 27981791     DOI: 10.1111/1754-9485.12568

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  7 in total

1.  Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.

Authors:  Youcai Li; Jun Zhang; Jiamei Gu; Kongzhen Hu; Shun Huang; Peter S Conti; Hubing Wu; Kai Chen
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

Review 2.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

3.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

4.  Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.

Authors:  Hyun A Kim; Kyung Ah Kim; Joon-Il Choi; Jeong Min Lee; Chang Hee Lee; Tae Wook Kang; Young-Mi Ku; Su Lim Lee; Yang Shin Park; Jeong Hee Yoon; Seong Hyun Kim; Moon Hyung Choi
Journal:  BMC Cancer       Date:  2017-12-21       Impact factor: 4.430

Review 5.  Implication of the Hedgehog pathway in hepatocellular carcinoma.

Authors:  Carminia Maria Della Corte; Giuseppe Viscardi; Federica Papaccio; Giovanna Esposito; Giulia Martini; Davide Ciardiello; Erika Martinelli; Fortunato Ciardiello; Floriana Morgillo
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

6.  Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017).

Authors:  Ying Ding; Sheng-Xiang Rao; Wen-Tao Wang; Cai-Zhong Chen; Ren-Chen Li; Mengsu Zeng
Journal:  Cancer Imaging       Date:  2018-12-07       Impact factor: 3.909

Review 7.  Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update.

Authors:  Tae-Hyung Kim; So Yeon Kim; An Tang; Jeong Min Lee
Journal:  Clin Mol Hepatol       Date:  2019-02-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.